Actively Recruiting
Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation
Led by University of Trieste · Updated on 2024-05-02
60
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chronic obstructive pulmonary disease (COPD) exacerbations are risk factors for disease progression and short-term re- hospitalizations. We propose a randomized controlled trial to evaluate the efficacy of a one-device multiparameter telemonitoring in reducing functional decline, symptoms, and risk of re-hospitalization of patients discharged after hospitalization for exacerbated COPD.
CONDITIONS
Official Title
Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to understand and sign the informed consent form
- Established diagnosis of COPD according to GOLD guidelines
- Diagnosis of COPD exacerbation at admission according to GOLD guidelines
- Arterial partial pressure of oxygen (PaO2) < 60 mmHg in ambient air at rest at admission and > 60 mmHg at discharge if not on long-term oxygen therapy or ventilation
- Arterial partial pressure of oxygen (PaO2) < 55 mmHg on usual oxygen supplement and > 60 mmHg on oxygen supplement at discharge if on long-term oxygen therapy or ventilation
- Age between 18 and 90 years at randomization
You will not qualify if you...
- Heart failure as the main cause of acute respiratory failure
- Acute pulmonary embolism or chronic pulmonary thromboembolism
- Interstitial lung disease as the main cause of acute respiratory failure
- Pneumonia as the main cause of acute respiratory failure
- Chronic renal failure with dialysis dependence
- Immunosuppression including cancer on treatment, post-organ transplantation, HIV-positive, or on immunosuppressant therapy
- Progressive neuro-muscular disorders
- Cognitive impairment, dementia, or decompensated psychiatric disorder
- Quadriplegia, hemiplegia, quadriparesis, or hemiparesis
- Do-not-resuscitate order
- Any condition that may significantly affect the patient's ability to comply with the study protocol according to the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
SC Pneumologia, Azienda Sanitaria Universitaria Giuliano-Isontina
Trieste, Italy, 34126
Actively Recruiting
Research Team
F
Francesco Salton, MD
CONTACT
M
Msrco Confalonieri, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here